| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/10/2002 | CA2413158A1 Ecm-related tumor marker |
| 01/10/2002 | CA2413128A1 Transporters and ion channels |
| 01/10/2002 | CA2412925A1 A novel app mutation associated with an unusual alzheimer's disease pathology |
| 01/10/2002 | CA2412882A1 Peptide extended glycosylated polypeptides |
| 01/10/2002 | CA2412872A1 Protein modification and maintenance molecules |
| 01/10/2002 | CA2412836A1 Peptide composition for treatment of periodontal diseases and prevention of skin aging |
| 01/10/2002 | CA2412077A1 I-superfamily conotoxins |
| 01/10/2002 | CA2411692A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | CA2410679A1 Secretion and trafficking molecules |
| 01/10/2002 | CA2408829A1 Regulated gene expression in yeast and methods of use |
| 01/10/2002 | CA2407910A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | CA2406649A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/09/2002 | EP1170592A1 Presentation of hydrophobic antigens to T-cells by CD1 molecules |
| 01/09/2002 | EP1170382A2 Method for diagnosing a bacterial infection in the crassostrea gigas oyster larvae |
| 01/09/2002 | EP1170372A1 Regulatory sequences of the human MCP-1 gene |
| 01/09/2002 | EP1170371A1 Phosphohexuloisomerase and gene therefor |
| 01/09/2002 | EP1170368A2 Immunization by inoculation of dna transcription unit |
| 01/09/2002 | EP1170367A1 BVDV virus-like particles |
| 01/09/2002 | EP1170365A1 Member of the ion channel family of polypeptides; vanilrep4 |
| 01/09/2002 | EP1170364A1 Mutations of cryptic splice sites in Cre and Cre-fusion proteins to improve the expression in inducibility |
| 01/09/2002 | EP1170302A1 An infectious bursal disease virus mutant and vaccines |
| 01/09/2002 | EP1170300A1 Method for modification of recombinant polypeptides |
| 01/09/2002 | EP1170016A2 Urease-based vaccine against helicobacter infection |
| 01/09/2002 | EP1170014A1 Proteoglycan, a bioactive substance from plants |
| 01/09/2002 | EP1169646A2 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases |
| 01/09/2002 | EP1169644A1 Method to type prion proteins |
| 01/09/2002 | EP1169642A1 Complex formed by n-linked glycoproteins (siblings) and factor h |
| 01/09/2002 | EP1169483A2 VARIATION IN DRUG RESPONSE RELATED TO POLYMORPHISMS IN $g(b) 2?- ADRENERGIC RECEPTOR |
| 01/09/2002 | EP1169481A1 Method of identifying toxic agents using differential gene expression |
| 01/09/2002 | EP1169469A1 Human colon cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1169465A1 Two-step immunization procedure against chlamydia infection |
| 01/09/2002 | EP1169463A1 Method for conveying bnyvv resistance to sugar beet plants |
| 01/09/2002 | EP1169460A2 Preparation of biologically active molecules |
| 01/09/2002 | EP1169457A2 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/09/2002 | EP1169456A1 Recombinant toxin a/toxin b vaccine against clostridium difficile |
| 01/09/2002 | EP1169455A1 Compounds and methods for the diagnosis and treatment of babesia microti infection |
| 01/09/2002 | EP1169454A1 Protein sweetener |
| 01/09/2002 | EP1169452A1 Viral variants |
| 01/09/2002 | EP1169451A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
| 01/09/2002 | EP1169450A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 01/09/2002 | EP1169449A2 Clasp-2 transmembrane proteins |
| 01/09/2002 | EP1169448A1 Tumor necrosis factor homologs and nucleic acids encoding the same |
| 01/09/2002 | EP1169447A1 Genes and expression products from hematopoietic cells |
| 01/09/2002 | EP1169446A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 01/09/2002 | EP1169445A2 Human proteins and polynucleotides encoding them |
| 01/09/2002 | EP1169444A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 01/09/2002 | EP1169443A1 REAGENTS AND METHODS FOR IDENTIFYING AND MODULATING EXPRESSION OF GENES REGULATED BY p21 |
| 01/09/2002 | EP1169442A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2002 | EP1169441A2 Treatment of cardiac power failure using s100 proteins |
| 01/09/2002 | EP1169440A1 48 human secreted proteins |
| 01/09/2002 | EP1169439A1 Combinatorial method for producing nucleic acids |
| 01/09/2002 | EP1169438A1 Pcr-based cloning method |
| 01/09/2002 | EP1169433A1 Human hac3 |
| 01/09/2002 | EP1169351A1 Polypeptides derived from endostatin exhibiting antiangiogenic activity |
| 01/09/2002 | EP1169350A2 Human obesity protein binding protein-2 homolog compositions and uses thereof |
| 01/09/2002 | EP1169349A2 Highly purified gonadotropin compositions and process for preparing them |
| 01/09/2002 | EP1169348A1 Purposeful movement of human migratory cells away from an agent source |
| 01/09/2002 | EP1169347A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/09/2002 | EP1169346A1 48 human secreted proteins |
| 01/09/2002 | EP1169345A2 Genes associated with diseases of the kidney |
| 01/09/2002 | EP1169344A1 47 human secreted proteins |
| 01/09/2002 | EP1169343A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 01/09/2002 | EP1169342A2 Tuberculosis antigens and methods of use therefor |
| 01/09/2002 | EP1169341A1 Infectious cdna clone of hepatitis e virus (hev) genome, its production and uses |
| 01/09/2002 | EP1169340A1 Lantibiotic |
| 01/09/2002 | EP1169334A1 48 human secreted proteins |
| 01/09/2002 | EP1169333A1 49 human secreted proteins |
| 01/09/2002 | EP1169282A1 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |
| 01/09/2002 | EP1169057A2 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 01/09/2002 | EP1169053A1 Pulmonary administration of dry powder formulations for treating infertility |
| 01/09/2002 | EP1168923A1 Dna vaccination for treatment of autoimmune disease |
| 01/09/2002 | EP1168917A2 Human lung cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1105516A4 Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular rna-protein fusion formation |
| 01/09/2002 | EP0984699A4 Method of inhibiting immune system destruction of transplanted viable cells |
| 01/09/2002 | EP0959907A4 The butyrophilin gene promoter and uses thereof |
| 01/09/2002 | EP0929663A4 Method of increasing growth and yield in plants |
| 01/09/2002 | EP0873354A4 Novel amp activated protein kinase |
| 01/09/2002 | EP0866806A4 Method of mobilizing hematopoietic stem cells |
| 01/09/2002 | EP0789764B1 A novel family of protease inhibitors, and other biologic active substances |
| 01/09/2002 | EP0767610B1 Bacillus thuringiensis isolates active against cockroaches |
| 01/09/2002 | EP0728146B1 Conotoxin peptides |
| 01/09/2002 | EP0714444B1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
| 01/09/2002 | EP0618813B1 Antigen of hybrid m protein and carrier for group a streptococcal vaccine |
| 01/09/2002 | EP0495811B1 Production of genetically-engineered vaccines for aids and other retroviral diseases |
| 01/09/2002 | CN1330718A Therapeutically active proteins in plants |
| 01/09/2002 | CN1330716A Method for control gene expression in bacterial, namely i(rhizobiaceae) to improved root nodule development, nitrogen fixation and plant blomass production |
| 01/09/2002 | CN1330715A Selectively replicating viral vectors |
| 01/09/2002 | CN1330714A Virulence genes and proteins and their use |
| 01/09/2002 | CN1330713A Zinc finger binding domains for GNN |
| 01/09/2002 | CN1330712A Biogical compositions, components thereof and uses therefor |
| 01/09/2002 | CN1330665A Multiple domain glycoprotein hormones and methods of using |
| 01/09/2002 | CN1330664A Platelet-derived growth factor C, DNA coding therefor and uses thereof |
| 01/09/2002 | CN1330663A Hypoxia-inducible factor I-alpha HIF-I-alpha variants and methods for identifying HIF-I-alpha modulators |
| 01/09/2002 | CN1330662A Heliobacter pylori antigen |
| 01/09/2002 | CN1330661A Procollagen C-proteinase inhibitors |
| 01/09/2002 | CN1330080A Polypeptide-human protein 10 containing P structure domain and polynucleotide for encoding it |
| 01/09/2002 | CN1330079A Polypeptide-RNA polymerase II associated protein 9.57 and polynucleotide for encoding it |
| 01/09/2002 | CN1330078A Polypeptide-negative regulatory factor 9.02 of protein activating GTP enzyme and polynucleotide for coding it |
| 01/09/2002 | CN1077438C Recombinant coccidiosis vaccines |
| 01/08/2002 | US6337432 A teratocyte secretory protein nucleic acid molecule; to induce larval development arrest and inhibit crop damage |